122 related articles for article (PubMed ID: 30266252)
1. IgM plasma cell myeloma in the era of novel therapy: a clinicopathological study of 17 cases.
Angelova EA; Li S; Wang W; Bueso-Ramos C; Tang G; Medeiros LJ; Lin P
Hum Pathol; 2019 Feb; 84():321-334. PubMed ID: 30266252
[TBL] [Abstract][Full Text] [Related]
2. IgM Plasma Cell Myeloma.
Lu H; Durkin L; Zhao X; Nakashima MO
Am J Clin Pathol; 2022 Jan; 157(1):47-53. PubMed ID: 34508562
[TBL] [Abstract][Full Text] [Related]
3. IgM myeloma: a rare entity characterized by a CD20-CD56-CD117- immunophenotype and the t(11;14).
Feyler S; O'Connor SJ; Rawstron AC; Subash C; Ross FM; Pratt G; Drayson MT; Ashcroft J; Cook G; Owen RG
Br J Haematol; 2008 Mar; 140(5):547-51. PubMed ID: 18275432
[TBL] [Abstract][Full Text] [Related]
4. Lymphoplasmacytic lymphoma with IgG or IgA paraprotein: a study of 29 cases including cases that can mimic plasma cell neoplasms.
Qiu L; Nwogbo OV; Medeiros LJ; Thakral B; Li S; Xu J; You MJ; Wang W; Quesada AE; Ramos CB; McDonnell TJ; Thomas SK; Lin P
Hum Pathol; 2022 Dec; 130():47-57. PubMed ID: 36244464
[TBL] [Abstract][Full Text] [Related]
5. [Immunoglobulin M multiple myeloma: a six-case report and literature review].
Yan WW; Fan HS; Xu JY; Liu JH; Du CX; Deng SH; Sui WW; Xu Y; Qiu LG; An G
Zhonghua Xue Ye Xue Za Zhi; 2021 Dec; 42(12):1011-1014. PubMed ID: 35045672
[No Abstract] [Full Text] [Related]
6. [Clinical and laboratory features of four cases with IgM multiple myeloma].
Fan JL; Fu WJ; Shi HT; Zhou F; Yuan ZG; Zhang CY; Wei W; Ye F; Zhang H; Hou J
Zhonghua Xue Ye Xue Za Zhi; 2013 Apr; 34(4):341-4. PubMed ID: 23668209
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD56 and CD19 in Patients with Newly Diagnosed Multiple Myeloma and Their Relationship with Karyotypes and Prognosis].
Qiu Q; Zhu P; Wang MJ; Lu XZ; Dong YJ; Sun YH; Wang LH; Zhang Y; Bu DF; Wang WS; Liang ZY; Liu W; Qiu ZX; Ou JP; Cen XN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Aug; 24(4):1071-8. PubMed ID: 27531777
[TBL] [Abstract][Full Text] [Related]
8. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
[TBL] [Abstract][Full Text] [Related]
9. CD20-negative low-grade B cell lymphoma showing immunophenotypic and genotypic features resembling plasma cell myeloma.
Tabata R; Yasumizu R; Tabata C; Kojima M
Pathol Res Pract; 2013 Jul; 209(7):459-62. PubMed ID: 23707547
[TBL] [Abstract][Full Text] [Related]
10. IgM myeloma: A multicenter retrospective study of 134 patients.
Castillo JJ; Jurczyszyn A; Brozova L; Crusoe E; Czepiel J; Davila J; Dispenzieri A; Eveillard M; Fiala MA; Ghobrial IM; Gozzetti A; Gustine JN; Hajek R; Hungria V; Jarkovsky J; Jayabalan D; Laubach JP; Lewicka B; Maisnar V; Manasanch EE; Moreau P; Morgan EA; Nahi H; Niesvizky R; Paba-Prada C; Pika T; Pour L; Reagan JL; Richardson PG; Shah J; Spicka I; Vij R; Waszczuk-Gajda A; Gertz MA
Am J Hematol; 2017 Aug; 92(8):746-751. PubMed ID: 28383205
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
12. IgM myeloma: a report of four cases.
Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
[TBL] [Abstract][Full Text] [Related]
13. IgM multiple myeloma: pathologic evaluation of a rare entity.
King RL; Howard MT; Hodnefield JM; Morice WG
Am J Clin Pathol; 2013 Oct; 140(4):519-24. PubMed ID: 24045549
[TBL] [Abstract][Full Text] [Related]
14. IgM myeloma, a distinct entity in the spectrum of B-cell neoplasia.
Zarrabi MH; Stark RS; Kane P; Dannaher CL; Chandor S
Am J Clin Pathol; 1981 Jan; 75(1):1-10. PubMed ID: 6779622
[TBL] [Abstract][Full Text] [Related]
15. Correlation of cytomorphology, immunophenotyping, and interphase fluorescence in situ hybridization in 381 patients with monoclonal gammopathy of undetermined significance and 301 patients with plasma cell myeloma.
Bacher U; Haferlach T; Kern W; Alpermann T; Schnittger S; Haferlach C
Cancer Genet Cytogenet; 2010 Dec; 203(2):169-75. PubMed ID: 21156229
[TBL] [Abstract][Full Text] [Related]
16. 14q32 Translocations discriminate IgM multiple myeloma from Waldenstrom's macroglobulinemia.
Avet-Loiseau H; Garand R; Lodé L; Robillard N; Bataille R
Semin Oncol; 2003 Apr; 30(2):153-5. PubMed ID: 12720126
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Involvement in Plasma Cell Myeloma.
Panse G; Subtil A; McNiff JM; Glusac EJ; Ko CJ; Galan A; Myung P; Xu ML
Am J Clin Pathol; 2021 Jan; 155(1):106-116. PubMed ID: 32885235
[TBL] [Abstract][Full Text] [Related]
18. [IgM myeloma: 6 cases and a review of the literature].
De Gramont A; Grosbois B; Michaux JL; Peny AM; Pollet JP; Smadja N; Krulik M; Debray J; Bernard JF; Monconduit M
Rev Med Interne; 1990; 11(1):13-8. PubMed ID: 2109345
[TBL] [Abstract][Full Text] [Related]
19. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Terpos E; Apperley JF; Samson D; Giles C; Crawley C; Kanfer E; Olavarria E; Goldman JM; Rahemtulla A
Bone Marrow Transplant; 2003 Feb; 31(3):163-70. PubMed ID: 12621476
[TBL] [Abstract][Full Text] [Related]
20. Lymphoplasmacytic Lymphoma With a Non-IgM Paraprotein Shows Clinical and Pathologic Heterogeneity and May Harbor MYD88 L265P Mutations.
King RL; Gonsalves WI; Ansell SM; Greipp PT; Frederick LA; Viswanatha DS; He R; Kyle RA; Gertz MA; Kapoor P; Morice WG; Howard MT
Am J Clin Pathol; 2016 Jun; 145(6):843-51. PubMed ID: 27329639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]